$NKE

Why is Nike stock tumbling today?

Nike (NKE) stock dropped 9.6% after reporting mixed Q1 2027 results: earnings beat estimates ($0.48 vs. $0.44) but revenue missed ($11.21B vs. $11.35B). Full-year guidance was significantly lower than expected, with revenue projected to fall in the high single digits and EPS between $1.15 and $1.35. China sales declined 26%, and the company announced a restructuring plan targeting $2.5B in savings by 2031.

Original reporting
Published Oct 2, 2026, 8:43 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 2, 2026, 8:49 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$NKE
Bearish
high confidence
Mentioned
$NKE
Relevance
9/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$NKEBearishHigh
01

Why it matters

The guidance miss and China sales decline are likely to keep the stock under pressure, especially ahead of the upcoming earnings season for peers.

02

Market read

Nike's 9% pre‑market slide reflects a material earnings surprise and guidance downgrade, making it a high‑impact trading story.

03

What to watch

Potential upside from upcoming product launches or a rebound in North American demand may be under‑appreciated.

Relevance 9/10Novelty 9/10Timing: pre‑market today

Background

Nike's Q1 earnings beat EPS expectations but missed revenue, with a stark full‑year guidance cut and a 26% drop in Greater China sales.

Company-level read

Ticker impact

$NKEBearishHigh confidence
Context

Nike reported Q1 earnings beat but missed revenue and cut full-year guidance, causing a 9.6% pre‑market drop.

Expected impact

likely pressure as the market prices in the revenue miss and guidance cut

Evidence & confidence

Guidance fell well below consensus and China sales collapsed 26%, prompting a sharp sell‑off.

Market effects

Discretionary apparel sector faces heightened risk as Nike's weakness may pressure peers.

China exposure concerns could affect other US brands with significant Greater China sales.

Broad market futures rose, but Nike's move is company‑specific and may dampen overall consumer‑stock sentiment.

Counterpoint

If Nike's restructuring delivers cost savings faster than expected, the stock could rebound on a turnaround narrative.

Key entities

  • Nike

    Global athletic footwear and apparel maker (ticker NKE).

  • Dave Denton

    Nike CFO who commented on the results.

Related articles

$NKEHigh

Jefferies cuts Nike stock price target on China, Jordan headwinds

Jefferies reduced its price target for Nike (NYSE: NKE) to $60 from $75, citing challenges in China and the Jordan brand. Nike's stock is down 51% over the past year. The company reported Q1 earnings beating estimates but missing revenue expectations, with a 26% decline in Greater China revenue. Nike projects a high-single-digit revenue decline for the fiscal year.

$NKEHighAI 9/10

Nike is taking on water from (almost) all sides

Nike reported a 4% revenue decline in Q1 2027, with management forecasting a 'high single-digit' decrease for the full fiscal year. Sales fell in China, Europe, and other regions, while the direct-sales strategy underperformed. Converse sales halved. Cost cuts helped maintain margins, with EPS at $0.48 and a slight dividend increase. Share buybacks have halted.

$NKEMed

NKE Stock Heads For A Weekly Loss: Morningstar Says Nike's Fresh Cost Cuts Signal A Longer Road To Recovery

Nike (NKE) stock is down 1.6% this week, with a 8% drop in premarket trading. Morningstar warns of a longer recovery due to weak Q1 sales, lower fiscal 2027 guidance, and China challenges. Nike plans $2.5B in savings via 'Pace' initiative, targeting tech and supply chain. Earnings per share estimate lowered to $1.15-$1.35. Retail sentiment remains bullish despite a 44% YTD decline.

$NKEMed

Nike, Synaptics And 3 Stocks To Watch Heading Into Friday

Nike (NKE) reported mixed Q1 results, missing revenue estimates but beating earnings. Synaptics (SYNA) agreed to be acquired by ON Semiconductor (ON) for $123 per share. Edwards Lifesciences (EW) received FDA approval for a pediatric valve. AsiaStrategy (SORA) and Mangoceuticals (MGRX) made announcements, causing after-hours price swings.